RIFAMPIN and NAUSEA

Overview

NAUSEA is the #5 most commonly reported adverse reaction for RIFAMPIN, manufactured by Sanofi-Aventis U.S. LLC. There are 630 FDA adverse event reports linking RIFAMPIN to NAUSEA. This represents approximately 2.8% of all 22,393 adverse event reports for this drug.

Patients taking RIFAMPIN who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

NAUSEA is a less commonly reported adverse event for RIFAMPIN, but still significant enough to appear in the safety profile.

Other Side Effects of RIFAMPIN

In addition to nausea, the following adverse reactions have been reported for RIFAMPIN:

• DRUG INEFFECTIVE — 1,468 reports
• OFF LABEL USE — 1,107 reports
• DRUG INTERACTION — 970 reports
• DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS — 727 reports
• CONDITION AGGRAVATED — 550 reports
• PYREXIA — 541 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 533 reports
• VOMITING — 445 reports
• DRUG RESISTANCE — 437 reports
• ACUTE KIDNEY INJURY — 396 reports

Other Drugs Associated with NAUSEA

The following drugs have also been linked to nausea in FDA adverse event reports:

Does RIFAMPIN cause NAUSEA?

NAUSEA has been reported as an adverse event in 630 FDA reports for RIFAMPIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is NAUSEA with RIFAMPIN?

NAUSEA accounts for approximately 2.8% of all adverse event reports for RIFAMPIN, making it a notable side effect.

What should I do if I experience NAUSEA while taking RIFAMPIN?

If you experience nausea while taking RIFAMPIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages